Warfarin protocol yields big reduction in adverse drug events.
D000925:Anticoagulants / Q000009:adverse effects*; D002985:Clinical Protocols; D016903:Drug Monitoring; D006801:Humans; D009657:North Carolina; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D014859:Warfarin